Rxcurve
HCPCS J3385 · per 100 UNITS

Velaglucerase alfa

Products billed under this code include Vpriv.

Payment limit per 100 UNITS, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J3385

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Vpriv Takeda Pharmaceuticals America, Inc. 54092-0701-04 4 $1,575.716

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $393.929 +$1.086 100 UNITS Velaglucerase alfa v1, posted September 17, 2026
3Q26 $392.843 +$4.686 100 UNITS Velaglucerase alfa v1, posted September 15, 2026
2Q26 $388.157 +$1.729 100 UNITS Velaglucerase alfa v1, posted September 15, 2026
1Q26 $386.428 +$5.068 100 UNITS Velaglucerase alfa v1, posted September 15, 2026
4Q25 $381.36 +$1.177 100 UNITS Velaglucerase alfa v1, posted September 8, 2026
3Q25 $380.183 +$5.823 100 UNITS Velaglucerase alfa v1, posted March 10, 2026
2Q25 $374.36 +$0.341 100 UNITS Velaglucerase alfa v1, posted March 10, 2026
1Q25 $374.019 +$3.819 100 UNITS Velaglucerase alfa v1, posted December 19, 2025
4Q24 $370.20 +$0.717 100 UNITS Velaglucerase alfa v1, posted June 11, 2025
3Q24 $369.483 +$1.642 100 UNITS Velaglucerase alfa v1, posted June 11, 2025
2Q24 $367.841 +$0.435 100 UNITS Velaglucerase alfa v1, posted March 11, 2025
1Q24 $367.406 +$1.011 100 UNITS Velaglucerase alfa v1, posted December 19, 2024
4Q23 $366.395 −$0.786 100 UNITS Velaglucerase alfa v1, posted October 10, 2024
3Q23 $367.181 +$9.835 100 UNITS Velaglucerase alfa v1, posted June 5, 2024
2Q23 $357.346 −$0.182 100 UNITS Velaglucerase alfa v1, posted February 23, 2024
1Q23 $357.528 −$1.367 100 UNITS Velaglucerase alfa v1, posted December 6, 2023
4Q22 $358.895 −$0.837 100 UNITS Velaglucerase alfa v1, posted June 22, 2023
3Q22 $359.732 −$0.184 100 UNITS Velaglucerase alfa v1, posted June 9, 2023
2Q22 $359.916 +$0.12 100 UNITS Velaglucerase alfa v1, posted December 14, 2022
1Q22 $359.796 +$0.505 100 UNITS Velaglucerase alfa v1, posted June 8, 2022
4Q21 $359.291 +$1.698 100 UNITS Velaglucerase alfa v1, posted June 2, 2022
3Q21 $357.593 +$11.132 100 UNITS Velaglucerase alfa v1, posted June 2, 2022
2Q21 $346.461 −$0.164 100 UNITS Velaglucerase alfa v1, posted March 1, 2022
1Q21 $346.625 – 100 UNITS Velaglucerase alfa v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files